Digital monitoring to catch liver cancer risk early
Part of Cancer, Digestive system, Infections clinical trials.
This study tests a digital (computer/phone-based) system to help track people with higher risk of liver cancer so cancers can be found earlier. It may help by guiding regular check-ins and making early diagnosis more efficient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Have at least one liver cancer risk condition: hepatitis B, hepatitis C, cirrhosis, fatty liver with advanced scarring, or certain metabolic/glucose issues
- If you have fatty liver, you likely need test results showing significant liver scarring (and sometimes abnormal glucose or diabetes/prediabetes)
- Have not been diagnosed with liver cancer before joining
- Cannot be pregnant, breastfeeding, or trying to become pregnant
- Able to understand the study, agree to participate, and follow the study steps; no severe mental illness/cognitive problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares ultrasound scans versus MRI scans to see which one better helps prevent deaths from liver cancer in people with cirrhosis. You may be assigned to one of the two imaging tests and follow-up visits to track whether liver cancer develops or is caught early.
This study tests whether adding a simple blood test (GAAD score) to a routine liver ultrasound can find early-stage liver cancer sooner in people with chronic liver conditions. It aims to improve detection in Asian populations at risk.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This trial is testing a routine screening program for liver cancer (hepatocellular carcinoma) in people who are at higher risk of developing it. The goal is to catch cancer early, when treatment works best.
Hear when a new Hepatitis C, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.